MARMITE maker Unilever yesterday defended its £50billion bid for GlaxoSmithKline's consumer healthcare arm as the megabucks swoop triggered a slump in its share price. -»
Unilever shares fall after £50bn GSK bid is rejected
Reviewed by Unknown
on
18 January
Rating:
No comments:
Post a Comment